New use of Aspirin: Reduces the risk of bowel cancer

Scientists have discovered a new use of Aspirin, taking 1 dose of aspirin every day for 5 years, reducing the risk of bowel cancer by more than 70% in the following decades. The new conclusion is based on a survey of 7,500 people

This research - just published in the British medical journal The Lancet - is based on a database of two large and long-term trials in the UK in the late 1970s and early 80s. , with the participation of 7,500 people.

According to research results, people who drink 300mg of aspirin daily for 5 years will reduce the risk of bowel cancer by 74% in the next 10-15 years (Photo: wkrn)

These people were given aspirin or placebo doses for 5 to 7 years. Later, their health status was monitored for the next 20 years, and all cases of bowel cancer deaths were recorded.

The study results showed that those who drank 300mg of Aspirin - equivalent to 1 tablet / day for 5 years will reduce the risk of bowel cancer by 74% in the next 10 - 15 years.

According to experts, monitoring for a long time after 5 years of taking drugs is necessary because 10 years of time for pre-cancer cases to develop into true cancer.

During the study, scientists also synthesized the results of 30 relevant survey studies. Accordingly, taking aspirin in moderate to high doses for 10 years or more will help reduce the risk of bowel cancer by 50-70%. This suggests that there is a similarity between this study and other studies on Aspirin's prevention of bowel cancer.

According to the team, this effect of Aspirin is not affected by factors such as age, gender, race and country. The study also looked at individuals with a family history of bowel cancer - a factor that increases the risk of developing the disease two to four times throughout life. Lead researcher Peter Rothwell said: 'What we want to emphasize is that for high-risk groups, taking aspirin will greatly reduce that risk.'

Aspirin prevents cancer? - Exercise and proper nutrition are still more .

According to cancer experts, this is the first study of bowel cancer that uses a control group and participants are given different doses of aspirin.

'The results of this study are not an incentive for everyone to take aspirin daily, especially high doses.'(Photo: Ehponline.org)

In an article in the Lancet, Dr. Andrew Chan, of Massachusetts General Hospital in Boston, USA, said the study was a "convincing evidence" of the effect of aspirin on cancer prevention. intestine - an annual disease that kills 16,000 people in the UK. But he added that this study is not enough to give advice to people who should take Aspirin to prevent cancer.

Meanwhile, Rob Glynne-Jones, Bowel Cancer UK's chief medical adviser, a bowel cancer charity in the UK, also said: 'Taking high doses of aspirin for a long time can lead to potentially serious side effects in some people '.

According to Dr. Kat Arney, of the British Cancer Research Institute, this study provides more evidence that aspirin has the potential to prevent bowel cancer. However, according to her, 'eating lots of vegetables and fruits, regularly exercising and maintaining a reasonable weight are also factors that contribute to reducing the risk of cancer, including cancer. intestine'.

British cancer, this study provides further evidence that aspirin has the potential to prevent bowel cancer. However, according to her, 'eating lots of vegetables and fruits, regularly exercising and maintaining a reasonable weight are also factors that contribute to reducing the risk of cancer, including cancer. intestine'.

Quang Thinh

According to BBC / Cancer Page / Independent / The Herald, VietNamNet